OC
SRCL

Oppenheimer & Co’s Stericycle Inc SRCL Stock Holding History

Oppenheimer & Co’s Portfolio SRCL Stock Details SRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,737
Closed -$983K – 1593
2021
Q2 		$983K Buy
13,737
+196
+1% +$14.4K 0.02% 758
2021
Q1 		$914K Buy
13,541
+300
+2% +$20.4K 0.02% 734
2020
Q4 		$918K Sell
13,241
-78
-0.6% -$5.34K 0.02% 677
2020
Q3 		$840K Buy
13,319
+9,441
+243% +$580K 0.02% 650
2020
Q2 		$217K Sell
3,878
-512
-12% -$26.7K 0.01% 1086
2020
Q1 		$213K Sell
4,390
-155
-3% -$9.13K 0.01% 1013
2019
Q4 		$290K Sell
4,545
-118
-3% -$6.98K 0.01% 1036
2019
Q3 		$237K Sell
4,663
-2,571
-36% -$120K 0.01% 1071
2019
Q2 		$345K Sell
7,234
-79
-1% -$4.02K 0.01% 954
2019
Q1 		$398K Sell
7,313
-696
-9% -$31.5K 0.01% 911
2018
Q4 		$294K Sell
8,009
-1,144
-12% -$53.7K 0.01% 952
2018
Q3 		$537K Sell
9,153
-1,895
-17% -$121K 0.01% 837
2018
Q2 		$721K Buy
11,048
+2,601
+31% +$162K 0.02% 713
2018
Q1 		$494K Buy
8,447
+577
+7% +$39.1K 0.01% 860
2017
Q4 		$535K Sell
7,870
-1,042
-12% -$70.7K 0.01% 838
2017
Q3 		$638K Sell
8,912
-171
-2% -$12.6K 0.02% 767
2017
Q2 		$693K Sell
9,083
-2,786
-23% -$229K 0.02% 718
2017
Q1 		$984K Buy
11,869
+375
+3% +$30.1K 0.03% 585
2016
Q4 		$885K Buy
+11,494
New +$868K 0.03% 600
2016
Q3 		– Sell
-18,246
Closed -$1.9M – 1315
2016
Q2 		$1.9M Sell
18,246
-135
-0.7% -$14.4K 0.06% 381
2016
Q1 		$2.32M Buy
18,381
+2,627
+17% +$306K 0.07% 316
2015
Q4 		$1.9M Buy
15,754
+1,281
+9% +$163K 0.06% 362
2015
Q3 		$2.02M Buy
14,473
+5,893
+69% +$820K 0.06% 358
2015
Q2 		$1.15M Sell
8,580
-913
-10% -$125K 0.03% 581
2015
Q1 		$1.33M Sell
9,493
-464
-5% -$62.6K 0.04% 536
2014
Q4 		$1.3M Buy
9,957
+657
+7% +$82.7K 0.04% 527
2014
Q3 		$1.08M Sell
9,300
-132
-1% -$15.6K 0.03% 579
2014
Q2 		$1.12M Buy
9,432
+860
+10% +$98.4K 0.03% 580
2014
Q1 		$974K Sell
8,572
-3,733
-30% -$432K 0.03% 610
2013
Q4 		$1.43M Buy
12,305
+628
+5% +$73.2K 0.05% 443
2013
Q3 		$1.35M Sell
11,677
-459
-4% -$52.9K 0.05% 431
2013
Q2 		$1.34M Buy
+12,136
New +$1.32M 0.05% 416

Other funds holding SRCL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

Oppenheimer & Co's SRCL Position: Q3 2021 in Review

Oppenheimer & Co sold out of Stericycle Inc (SRCL) in Q3 2021, closing a stake of 13,737 shares — an estimated $983K sold.

Oppenheimer & Co first reported a position in SRCL in Q2 2013 and held it in 32 quarters. The position peaked at $2.32M in Q1 2016. 337 funds tracked by Wall St. Rank hold SRCL as of Q3 2021.

  • Oppenheimer & Co reported no remaining Stericycle Inc position as of Q3 2021 after selling out during the quarter.
  • Oppenheimer & Co sold 13,737 Stericycle Inc shares in Q3 2021, an estimated $983K.
  • Oppenheimer & Co first reported a position in Stericycle Inc in Q2 2013 and held it in 32 quarters.
  • Oppenheimer & Co's Stericycle Inc position peaked at $2.32M in Q1 2016.
  • 337 funds tracked by Wall St. Rank held Stericycle Inc as of Q3 2021.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.